Department of Molecular Biosciences, the Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.
A blog that publishes updates and open access scientific papers about allergy, asthma and immunology. Editor: Juan Carlos Ivancevich, MD. Specialist in Allergy & Immunology
September 15, 2014
Exogenous interleukin-10 alleviates allergic inflammation but inhibits local interleukin-10 expression in a mouse allergic rhinitis model.
Twenty-first century mast cell stabilizers
Review
You have free access to this content
- D F Finn and
- J J Walsh*
Article first published online: 15 AUG 2013
DOI: 10.1111/bph.12138
© 2013 The Authors. British Journal of Pharmacology © 2013 The British Pharmacological Society
Issue
British Journal of Pharmacology
Special Issue: Themed Issue: Histamine Pharmacology Update. Guest Editor: Paul L Chazot
Impact of endobronchial allergen provocation on macrophage phenotype in asthmatics
Depigmented-polymerised allergoids favour regulatory over effector T cells: enhancement by 1α, 25-dihydroxyvitamin D3
Research article
Zoe L Urry1, David F Richards1, Cheryl Black1, Maria Morales2, Jerónimo Carnés2,Catherine M Hawrylowicz1*† and Douglas S Robinson3*†
- *Corresponding authors: Catherine M Hawrylowiczcatherine.hawrylowicz@kcl.ac.uk - Douglas S Robinsond.s.robinson@imperial.ac.uk
- † Equal contributors
1Department of Allergy and Asthma, MRC and Asthma UK Centre for Mechanisms of Allergic Asthma, Guy’s Campus, King’s College London, London, UK
2Department of Research and Development, Laboratorios Leti, Tres Cantos, Madrid, Spain
3Leukocyte Biology Section, MRC and Asthma UK Centre for Mechanisms of Allergic Asthma, NHLI, Imperial College London, London, UK
For all author emails, please log on.
The electronic version of this article is the complete one and can be found online at:http://www.biomedcentral.com/1471-2172/15/21
Received: | 30 October 2013 |
Accepted: | 16 May 2014 |
Published: | 29 May 2014 |
© 2014 Urry et al.; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
September 14, 2014
A Long-Term Risk? Prenatal POPs Exposure and Asthma in Young Adults
Lindsey Konkel is a Worcester, MA–based journalist who reports on science, health, and the environment. She is an editor for Environmental Health News and The Daily Climate.
About This Article open
“The focus in immunotoxicity studies has often been on immunologic intermediates, such as immune cell counts. This study is unique in that it looks at a long-term clinically relevant outcome,” says Todd Jusko, an environmental epidemiologist at the University of Rochester, who was not involved in the study.lthough previous research has suggested that prenatal exposures to persistent organic pollutants (POPs) may be harmful to a child’s developing immune system,1 few studies have investigated long-term outcomes in this regard. Findings reported in this issue of EHP provide evidence that exposure to certain POPs in the womb may be associated with an increased risk of developing asthma that persists into young adulthood.2
Asthma and respiratory physiology: Putting lung function into perspective
Invited Review Series: Respiratory Disease: Using Lung Function Measurements to Greater Advantage
You have free access to this content
- Giuseppe Francesco Sferrazza Papa1,
- Giulia Michela Pellegrino1 and
- Riccardo Pellegrino2,*
Article first published online: 24 JUL 2014
DOI: 10.1111/resp.12355
© 2014 Asian Pacific Society of Respirology
Additional Information(Show All)
- The Authors: Giuseppe Francesco Sferrazza Papa, MD, is a Fellow in Respiratory Medicine with interest in chronic obstructive pulmonary diseases, lung function and imaging techniques. Giulia Michela Pellegrino, MD, is a Fellow in Respiratory Medicine with interest in chronic obstructive pulmonary diseases, lung function and clinical research. Riccardo Pellegrino, MD, is Chief of the Department of Allergology and Respiratory Pathophysiology with interest in chronic obstructive pulmonary diseases, lung and airway mechanics, airway hyperresponsiveness and exercise physiology.
- Series Editors: Graham L. Hall and Charles G. Irvin
September 13, 2014
A genome-wide association study of bronchodilator response in asthmatics
- NIHPA Author Manuscripts
- PMC3706515
-
Pharmacogenomics J. Author manuscript; available in PMC Aug 1, 2014.
Published in final edited form as:
PMCID: PMC3706515
NIHMSID: NIHMS442409
A genome-wide association study of bronchodilator response in asthmatics
Qing Ling Duan, PhD,1,* Jessica Lasky-Su, ScD,1,* Blanca E. Himes, PhD,1,2 Weiliang Qiu, PhD,1 Augusto A. Litonjua, MD, MPH,1,3 Amy Damask, PhD,5 Ross Lazarus, MB, BS,1 Barbara Klanderman, PhD,1 Charles G. Irvin, PhD,6Stephen P. Peters, MD, PhD,7 John P. Hanrahan, MD, MPH,8 John J. Lima, PharmD,9 Fernando D. Martinez, MD,10David Mauger, PhD,11 Vernon M. Chinchilli, PhD,11 Manuel Soto-Quiros, PhD,12 Lydiana Avila, MD,12 Juan C. Celedón, MD, DrPH,13 Christoph Lange, PhD,4 Scott T. Weiss, MD, MS,1,2,3,4 and Kelan G. Tantisira, MD, MPH1,3
Subscribe to:
Posts (Atom)